We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

61 hedge funds and large institutions have $723M invested in Legend Biotech in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 9

22% more funds holding

Funds holding: 50 → 61 (+11)

0.35% more ownership

Funds ownership: 9.3% → 9.65% (+0.35%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 16

4% less capital invested

Capital invested by funds: $751M → $723M (-$27.8M)

Holders
61
Holders Change
+11
Holders Change %
+22%
% of All Funds
1.08%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
20
Increased
16
Reduced
16
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Federated Hermes
Federated Hermes
Pennsylvania
+$22.5M
2
WP
Woodline Partners
California
+$12.4M
3
BG
Bellevue Group
Switzerland
+$12M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$7.85M
5
AA
ALPS Advisors
Colorado
+$6.87M

Top Sellers

1
VC
Vivo Capital
California
-$16.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$13.2M
3
TAMH
Taikang Asset Management (HK)
Hong Kong
-$8.15M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.98M
5
MICM
Matthews International Capital Management
California
-$5.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACH
26
ArrowMark Colorado Holdings
Colorado
$5.51M +$4.2M +145,856 +292%
BlackRock
27
BlackRock
New York
$5.42M +$5.54M +192,472 New
Nomura Holdings
28
Nomura Holdings
Japan
$3.85M -$1.29K -45 -0%
BBA
29
Baker Bros. Advisors
New York
$3.26M -$362K -12,574 -10%
Morgan Stanley
30
Morgan Stanley
New York
$3.19M +$2.58M +89,784 +379%
State Street
31
State Street
Massachusetts
$2.31M +$2.37M +82,181 New
VIA
32
Vident Investment Advisory
Georgia
$1.83M +$676K +23,489 +56%
DVF
33
Discovery Value Fund
Singapore
$1.77M +$1.81M +62,783 New
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$1.37M -$41.2K -1,431 -3%
JP Morgan Chase
35
JP Morgan Chase
New York
$1.14M +$83.9K +2,916 +8%
MS
36
Maven Securities
Jersey
$1.08M +$1.06M +36,741 New
PA
37
Perceptive Advisors
New York
$704K – – –
Geode Capital Management
38
Geode Capital Management
Massachusetts
$484K +$166K +5,783 +51%
TD Asset Management
39
TD Asset Management
Ontario, Canada
$454K +$46.1K +1,600 +11%
Goldman Sachs
40
Goldman Sachs
New York
$408K +$417K +14,483 New
CS
41
Credit Suisse
Switzerland
$371K +$379K +13,175 New
VEA
42
Virtus ETF Advisers
New York
$277K +$283K +9,834 New
CSS
43
Cubist Systematic Strategies
Connecticut
$271K +$42.8K +1,486 +18%
AC
44
Athanor Capital
New York
$235K +$240K +8,329 New
Arrowstreet Capital
45
Arrowstreet Capital
Massachusetts
$233K +$238K +8,279 New
CF
46
CNA Financial
Illinois
$208K -$17.6K -610 -8%
TRCT
47
Tower Research Capital (TRC)
New York
$188K +$191K +6,629 +9,470%
DekaBank Deutsche Girozentrale
48
DekaBank Deutsche Girozentrale
Germany
$173K +$173K +6,000 New
Fidelity Investments
49
Fidelity Investments
Massachusetts
$163K -$7.98M -277,101 -98%
Deutsche Bank
50
Deutsche Bank
Germany
$147K -$115 -4 -0.1%
1
2
3

LEGN Hedge Fund Activity: Q4 2020 in Review

61 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q4 2020, worth a combined $723M — down 3.7% from $751M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new LEGN positions and 9 closed out — a net gain of 11 holders — while 16 added to existing stakes and 16 trimmed.

The largest buyer was Federated Hermes, adding an estimated $22.5M. The largest seller was Vivo Capital, cutting an estimated $16.6M.

  • 61 institutional investors held Legend Biotech (LEGN) as of Q4 2020, up from 50 in Q3 2020.
  • Funds reported $723M of Legend Biotech stock for Q4 2020, down 3.7% quarter-over-quarter.
  • 20 funds opened new Legend Biotech positions in Q4 2020 and 9 closed out, a net change of +11 holders.
  • The largest Legend Biotech buyer in Q4 2020 was Federated Hermes, an estimated $22.5M added.
  • The largest Legend Biotech seller in Q4 2020 was Vivo Capital, an estimated $16.6M sold.

Based on aggregated 13F filings for Q4 2020.